newsfilter
← Latest News
GlobeNewswire·

Brickell Biotech Regains Compliance with Nasdaq Minimum Bid Price Requirement

BOULDER, Colo., July 20, 2022 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. ("Brickell") (NASDAQ:BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for th